Kennewick, Wash.-based Trios Health will temporarily end its medical oncology services Dec. 13 due to staff shortages, the Tri-City Herald reported.
Oncology
New Brunswick-based Rutgers Cancer Institute of New Jersey and RWJBarnabas Health in West Orange, N.J., have named Louise Ligresti, MD, as chief of cancer survivorship.
A recent analysis found multiple myeloma patients in real-world settings have worse outcomes from standard regimens compared to those reported in clinical trials.
A study by New York City-based NYU Langone Health found a combination of a drug and protein fragment that prevents the growth of blood cancer cells.
With 16 cancer drugs currently on the FDA's drug shortage list, Jason Westin, MD, the director of Houston-based MD Anderson Cancer Center's Lymphoma Clinical Research Program, section chief for Aggressive Lymphoma, told the Senate Finance Committee Dec. 5 that "providers…
Atlanta-based Piedmont Oncology Institute named Walter Curran Jr., MD, its new chief.
Doris Ranski-Zazula, BSN, RN, was appointed vice president of the Detroit-based Karmanos Cancer Network, part of McLaren Health Care.
Researchers at Santa Monica, Calif.-based Providence Saint John’s Health Center published new findings from a clinical trial that shed light on a possible treatment for a rare spine cancer.
A partnership between Durham, N.C.,-based Duke University School of Medicine and Houston-based University of Texas MD Anderson Cancer Center has led to the early discovery of a potential method that may be capable of protecting bones from damage during cancer…
LSU Health, LCMC Health, Louisiana Cancer Research Center and Tulane University, all based in New Orleans, are collaborating to bring the state's first National Cancer Institute-designated cancer center, but recruitment efforts stand in the way, nola.com reported Dec. 4.
